May 23, 2022 4:05pm EDT Immunovant to Present at the H.C. Wainwright Global Investment Conference on May 25th
May 04, 2022 8:00am EDT Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th
Feb 09, 2022 8:00am EST Immunovant to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Dec 30, 2021 7:00am EST Immunovant Provides Regulatory Update Regarding Initiation of Phase 3 Trial for Batoclimab in Myasthenia Gravis in the First Half of 2022